PCSK9 inhibitior bococizumab produces varying results

Short resume:

request
80%
published
80%
updates
80%
national
80%

Date: March 17, 2017; Source: Brigham and Women’s Hospital; Summary: Researchers report that bococizumab had short-term benefits on lowering cholesterol levels and significantly reduced the risk of cardiovascular events by 21 percent compared to …
Source Science Daily
Read More…

More News

Be the first to comment

Leave a Reply

Your email address will not be published.


*